El programa Bind 4.0, la primera convocatoria de la aceleradora puesta en marcha por el Gobierno Vasco y diez compañías industriales punteras de Euskad, han elegido 18 proyectos más innovadores de 13 startups de Euskadi, resto del Estado, Portugal, Francia, Polonia e India. La iniciativa, presentada esta mañana en el Kursaal por la consejera Arantxa Tapia, posibilita trabajar en un proyecto común y establecer una relación en formato cliente-proveedor con algunas de las firmas más relevantes que operan en la comunidad autónoma.
The Walt Disney Co. is kicking off the third session of its corporate accelerator this week, and revealed 9 new companies admitted to the program. A full list follows at the end of this post.
The companies are developing everything from cinematic virtual reality and holographic content, to robots with human-like facial expressions.
Because alumni of the Disney Accelerator have scored big partnerships with the media and entertainment juggernaut in the past, it is seen as one of the more desirable corporate accelerators out there.
Subscription e-commerce as a category has seen funding collapse and some companies struggle. At least five of these companies died in 2015, including Beachmint which focused on celebrity-curated products.
Adents, the serialization and traceability software specialist, recently finalized a round of funding of 12 million euros, bringing to 20 million euros the total amount invested in the company over the last 18 months. This increase in capital was signed by Adents’ long time investors NAXICAP Partners, Omnes Capital and CapHorn Invest. The new funding will primarily support the further development of a global network of « solution partners » and gaining footholds in new international markets.
Over the last few years, Adents has emerged as one of the leading providers of versatile and easily deployable serialization and track-and-trace software solutions for the pharmaceutical and life sciences industries.
Robots might not be taking over the world yet but they’re certainly becoming ever more popular in the startup world.
Innovation and automation often come hand in hand these days, sometimes with physical robots, and other times with more subtle and clever AI algorithms as the backbone of services and apps. Below, we explore five of the coolest Australian bot-related startups featured on ProductHoist.
Originally born in Australia, this ambitious venture is looking to compete head-on with Google and Amazon to be the company spearheading the way in commercial drone deliveries.
I’d rather be sitting in the car with Eran Shir than driving the car in front of him, especially if I’m doing something I shouldn’t be while behind the wheel.
Shir is the cofounder and CEO of a startup called Nexar that’s making a smart dashcam app. It records your trips and uses phone-based machine learning and the sensors on your smartphone to do things like figure out when you’re in an accident and automatically upload a video of it to the Web.
Silicon Valley is justifiably seen as the geographical center of digital innovation. From Google and Facebook to Uber and Netflix, the Valley is home to many global technology leaders. However, when searching for the next big startup, the time has come to look beyond Silicon Valley.
The opportunity
It seems that most Western startups are focused on “assisted living for rich hipsters” rather than solving some of the “big” needs the world is facing.
During a week I spent trucking around the Paris ecosystem with a gaggle of international journalists, we were pitched by at least 30 startups who are doing everything from building some interesting apps to trying to reimagine the architecture of data centers.
It would be impossible to sort through all of them. But here are six that have really stuck with me in the weeks since that trip:
La semana pasada conocíamos como Elizabeth Holmes, la fundadora de Theranos, ha perdido toda su fortuna valorada en 4.500 millones de dólares. Su compañía de análisis de sangre a través de su sistema Edison, que supuestamente permitía realizar pruebas con tan sólo una gota de sangre tras una simple punción en un pulgar, ha resultado ser un fiasco a ojos de los reguladores de la Administración de Fármacos y Alimentos de Estados Unidos (FDA, por sus siglas en inglés).
